πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10034934

Porcine epidemic diarrhea virus vaccines and methods of use thereof

Regents of the University of Minnesota Β· Granted Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10023569

Methods of preparing inhibitors of influenza viruses replication

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10010599

Norovirus vaccine formulations

Takeda Vaccines, Inc. Β· Granted Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10010600

Compositions and methods for administration of vaccines against dengue virus

Takeda Vaccines, Inc. Β· Granted Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10012653

Nanoparticles for targeting acid tumor microenvironments

The Board of Regents of the University of Texas System Β· Granted Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10005833

Methods of treating inflammation associated airway diseases and viral infections

The Board of Regents of the University of Texas System Β· Granted Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10004751

Compositions and methods for treating Dengue virus infection

The Regents of the University of California Β· Granted Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10000556

Single-domain VHH antibodies directed to norovirus GI.1 and GII.4 and their use

The United States of America as Represented by the Secretary, Dept. of Health and Human Services Β· Granted Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10000522

Derivatives of uridine 5β€²-cyclophosphate useful to treat hepatitis C viral infections

Ligand Pharmaceuticals Incorporated Β· Granted Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9993545

Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vacc

Inovio Pharmaceuticals, Inc. Β· Granted Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9993543

Immunogenic compositions comprising silicified virus and methods of use

Providence Health & Servicesβ€”Oregon Β· Granted Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9987350

Antigens and vaccines directed against human enteroviruses

SENTINEXT THERAPEUTICS Sdn Bhd Β· Granted Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9987347

Vaccines against multiple subtypes of dengue virus

Inovio Pharmaceuticals, Inc. Β· Granted Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9982261

Antisense antiviral compounds and methods for treating a filovirus infection

Sarepta Therapeutics, Inc. Β· Granted Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9981034

Compositions and methods for vaccination against influenza A virus

SOUTH DAKOTA BOARD OF REGENTS Β· Granted Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9974800

Therapy for inhibition of single-stranded RNA virus replication

RedHill Biopharma Ltd. Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9974851

Human rotavirus vaccine strains and diagnostics

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9975926

Methods of making and using vaccines utilizing minicircle DNA expression vectors for produ

The United States of America, as represented by the Secretary of Homeland Security Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9969777

Mutant spike protein extending the tissue tropism of infectious bronchitis virus (IBV)

The Pirbright Institute Β· Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9968669

Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndro

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9957486

Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization

The United States of America as Represented by the Secretary, Dept. of Health and Human Services Β· Granted Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9951118

Engineering antiviral T cell immunity through stem cells and chimeric antigen receptors

The Regents of the University of California Β· Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9938236

Antiviral agents against HBV infection

ARBUTUS BIOPHARMA CORPORATION Β· Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9938589

Compositions and methods for detecting human pegivirus 2 (HPgV-2)

The Regents of the University of California Β· Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted